These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 955362)

  • 21. An analysis of epidemic factors in cervical cancer by conditional logistic regression model.
    Chen YX; Liao CS; Yang XZ; Zhang SJ; Xu JL; Jiao BG; Yu SZ; Zhang ZF; Ren QF
    Chin Med J (Engl); 1990 Jan; 103(1):55-60. PubMed ID: 2112444
    [No Abstract]   [Full Text] [Related]  

  • 22. [Epidemiology of cancer of the uterine cervix in Costa Rica, 1980-1983].
    Sierra R; Barrantes R
    Bol Oficina Sanit Panam; 1988 Oct; 105(4):345-52. PubMed ID: 2976596
    [No Abstract]   [Full Text] [Related]  

  • 23. [Population screening for cervix carcinoma in the city of Rotterdam, 1st round].
    van der Lee-Bijlsma A
    Ned Tijdschr Geneeskd; 1981 Dec; 125(49):2012-5. PubMed ID: 7322220
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cervical cancer and mass screening].
    Hakama M
    Duodecim; 1970; 86(5):270-6. PubMed ID: 5421372
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer screening. Past success and future challenge.
    Dewar MA; Hall K; Perchalski J
    Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Declining use of radiotherapy for invasive cervical cancer in Connecticut: 1983-1990.
    Polednak AP
    Gynecol Oncol; 1995 Aug; 58(2):226-9. PubMed ID: 7622109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications.
    Hakama M; Joutsenlahti U; Virtanen A; Räsänen-Virtanen U
    Ann Clin Res; 1975 Apr; 7(2):101-11. PubMed ID: 1181974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial dysplasia of the cervix uteri. The population screening for cervical carcinoma in the County of Maribo, 1967-69.
    Berget A
    Dan Med Bull; 1974 Aug; 21(5):169-71. PubMed ID: 4851895
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
    Juneja A; Murthy NS; Tuteja RK; Sardana S; Das DK
    Neoplasma; 1997; 44(4):272-4. PubMed ID: 9473783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast and cervical carcinoma: the correlation of activity limitations and rurality with screening, disease incidence, and mortality.
    Schootman M; Fuortes LJ
    Cancer; 1999 Sep; 86(6):1087-94. PubMed ID: 10491538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cytologic screening on the detection of cervical carcinoma.
    Yajima A; Mori T; Sato S; Wakisaka T; Suzuki M
    Obstet Gynecol; 1982 May; 59(5):565-8. PubMed ID: 7070726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gynecological screening in Sweden. Report of results and comparison with the cancer registry].
    Ericsson J; MattssonB ; Pettersson F
    Lakartidningen; 1975 Nov; 72(48):4719-24. PubMed ID: 1195913
    [No Abstract]   [Full Text] [Related]  

  • 34. Cervical cancer screening programs: summary of the 1982. Canadian task force report.
    Can Med Assoc J; 1982 Oct; 127(7):581-9. PubMed ID: 7127225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical cytology in Greenland and occurrence of cervical carcinoma, carcinoma in situ, and dysplasia. Extent and impact of uncoordinated screening activity 1976-1985.
    Højgaard Nielsen N; Jensen H; Hansen PK
    Arctic Med Res; 1988 Oct; 47(4):179-88. PubMed ID: 3214508
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cervix carcinoma and carcinoma in situ in the Haarlem region in the period 1965-1979].
    Oeberius Kapteyn JL
    Ned Tijdschr Geneeskd; 1981 Nov; 125(46):1865-9. PubMed ID: 7312058
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrocoagulation and the risk of cervical neoplasia.
    La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Gritti P
    Obstet Gynecol; 1985 Nov; 66(5):703-7. PubMed ID: 4058829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Carcinoma in situ of the cervix uteri in 3 years of research in La Serena].
    González R; Pescio S; Weber C; Ramirez J; Vera C
    Rev Chil Obstet Ginecol; 1977; 42(3):181-6. PubMed ID: 614667
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiology of cervical carcinoma in Brunei Darussalam. Analysis of data on 27,208 women screened with cytologic examinations.
    Affandi MZ; Dun T; Mantuano V; Sidhu R; Lumplugh C; Telisinghe PU
    Acta Cytol; 1993; 37(2):175-80. PubMed ID: 8465637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Increase of in-situ cervix uteri carcinoma in women under 35; data analysis from family practice 1974-1986].
    Boon ME; Rietveld WJ; de Graaff Guilloud JC
    Ned Tijdschr Geneeskd; 1988 Jul; 132(27):1240-3. PubMed ID: 2840584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.